4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-22-001700
Chief Medical Officer sold 15,000 shares at an average $31.66 ($474,968)
- Chief Medical Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Crystal Adam Chief Medical Officer | 2022-01-04 | Option exercise | +15,000 | $6.49 | $97,350 | 30,000 | D |
| Crystal Adam Chief Medical Officer | 2022-01-04 | Sale | −13,946 | $31.59 | $440,547 | 16,054 | D |
| Crystal Adam Chief Medical Officer | 2022-01-04 | Sale | −1,054 | $32.66 | $34,420 | 15,000 | D |
| Derivatives | |||||||
| Crystal Adam Chief Medical Officer | 2022-01-04 | Option exercise · Stock Option (Right to Buy) | −15,000 | 112,292 | D | ||
| Open-market sales · 15,000 sh · avg $31.66 · $474,968 | |||||||
Loading xslF345X03/doc4.xml…